Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology
Taipei, Taiwan
Medical center in Taipei
No. 201, Section 2, Shipai Rd, Beitou District, Taipei City, 112
About Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology
Taipei Veterans General Hospital is a national first-class medical center and a teaching hospital that provides tertiary patient care, undergraduate medical education programs and residency programs in Taiwan. It was founded in 1958 and administered by the Veterans Affairs Council.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Clinical Trials at Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology
During the past decade, Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations
2011-04-30
2016-12-30
Completed
208
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy
2014-03-11
2019-01-09
Completed
1,225
A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
2016-06-07
2022-07-07
Completed
403
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
2017-09-22
2024-04-27
Recruiting
1,000
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
2018-04-24
2025-01-19
Active, not recruiting
453
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
2020-03-04
2025-02-21
Recruiting
660
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
2020-08-24
2027-12-30
Active, not recruiting
800
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
2021-11-18
2026-03-06
Recruiting
690
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology"
#1 collaborator was "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology
According to Clinical.Site data, the most researched conditions in "Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology" are
"Non-Small Cell Lung Cancer" (2 trials), "Non-Squamous Non-Small Cell Lung Cancer" (2 trials), "Non-Small-Cell Lung" (1 trials), "Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology
Most popular intervention types in "Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (5 trials), "Carboplatin" (4 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (2 trials), "Cisplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology
The vast majority of trials in "Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology" are
8 trials for "All" genders.
Clinical Trials Status at Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology
Currently, there are NaN active trials in "Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Taipei Veterans General Hospital; Chest Dept , Section of Thoracic Oncology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".